Search research articles
Contact Us
Filters
Showing results (291-300 of 386) with videos related to
Page
of 39
Sort By:
Pharmacology & Therapeutics
|
February 9, 2006
mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine
Pankaj Gupta, Zao-zhong Su, Irina V Lebedeva, et al.
Autophagy
|
February 27, 2008
PERK-dependent regulation of MDA-7/IL-24-induced autophagy in primary human glioma cells
Margaret A Park, Adly Yacoub, Devanand Sarkar, et al.
Molecular Pharmacology
|
June 21, 2007
Low-dose BBR3610 toxicity in colon cancer cells is p53-independent and enhanced by inhibition of epidermal growth factor receptor (ERBB1)-phosphatidyl inositol 3 kinase signaling
Clint Mitchell, Peyman Kabolizadeh, John Ryan, et al.
Molecular Cancer Therapeutics
|
February 20, 2007
17-Allylamino-17-demethoxygeldanamycin enhances the lethality of deoxycholic acid in primary rodent hepatocytes and established cell lines
Clint Mitchell, Margaret A Park, Guo Zhang, et al.
Oncotarget
|
November 3, 2016
XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of IκBα and overcomes acquired proteasome inhibitor resistance in human multiple myeloma
Joel G Turner, Trinayan Kashyap, Jana L Dawson, et al.
Blood
|
May 31, 2008
A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia
Steven W Paugh, Barbara S Paugh, Mohamed Rahmani, et al.
Blood
|
August 13, 2015
Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation
Justin Sperlazza, Mohamed Rahmani, Jason Beckta, et al.
Journal of Hematology & Oncology
|
August 26, 2016
Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors
Joel G Turner, Jana L Dawson, Steven Grant, et al.
Molecular Pharmacology
|
April 20, 2006
OSU-03012 promotes caspase-independent but PERK-, cathepsin B-, BID-, and AIF-dependent killing of transformed cells
Adly Yacoub, Margaret A Park, David Hanna, et al.
Cancer Biology & Therapy
|
September 13, 2013
Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cells
Hossein A Hamed, Swadesh K Das, Upneet K Sokhi, et al.
Page
of 39
Search research articles
Search
Showing results (291-300 of 386) with videos related to
Sort By:
Page
of 39
Pharmacology & Therapeutics
|
February 9, 2006
mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine
Pankaj Gupta, Zao-zhong Su, Irina V Lebedeva, et al.
Autophagy
|
February 27, 2008
PERK-dependent regulation of MDA-7/IL-24-induced autophagy in primary human glioma cells
Margaret A Park, Adly Yacoub, Devanand Sarkar, et al.
Molecular Pharmacology
|
June 21, 2007
Low-dose BBR3610 toxicity in colon cancer cells is p53-independent and enhanced by inhibition of epidermal growth factor receptor (ERBB1)-phosphatidyl inositol 3 kinase signaling
Clint Mitchell, Peyman Kabolizadeh, John Ryan, et al.
Molecular Cancer Therapeutics
|
February 20, 2007
17-Allylamino-17-demethoxygeldanamycin enhances the lethality of deoxycholic acid in primary rodent hepatocytes and established cell lines
Clint Mitchell, Margaret A Park, Guo Zhang, et al.
Oncotarget
|
November 3, 2016
XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of IκBα and overcomes acquired proteasome inhibitor resistance in human multiple myeloma
Joel G Turner, Trinayan Kashyap, Jana L Dawson, et al.
Blood
|
May 31, 2008
A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia
Steven W Paugh, Barbara S Paugh, Mohamed Rahmani, et al.
Blood
|
August 13, 2015
Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation
Justin Sperlazza, Mohamed Rahmani, Jason Beckta, et al.
Journal of Hematology & Oncology
|
August 26, 2016
Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors
Joel G Turner, Jana L Dawson, Steven Grant, et al.
Molecular Pharmacology
|
April 20, 2006
OSU-03012 promotes caspase-independent but PERK-, cathepsin B-, BID-, and AIF-dependent killing of transformed cells
Adly Yacoub, Margaret A Park, David Hanna, et al.
Cancer Biology & Therapy
|
September 13, 2013
Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cells
Hossein A Hamed, Swadesh K Das, Upneet K Sokhi, et al.
Page
of 39